OCT is a leading CRO operating in Russia, Central and Eastern Europe and the CIS region. With a team of 200 professionals, OCT provides a full range of high-quality services in management of Phase I-IV and BE studies.
With local expertise and focus on quality, OCT ensures seamless clinical trial conduct and registration on time and within budget. Our experienced team delivers both standalone services such as medical writing, consultancy, project management/monitoring, data management/biostatistics and turnkey service for clinical development.
Since 2005, OCT has been working on 300 full-service and functional service projects in a number of therapeutic areas.
Our solid team consists of over 200 professionals. Our clinical team consists of highly qualified specialists with medical, pharmaceutical and chemical background. OCT is led by the team members who have been working for the company since
the day it was started.
Support and communication
OCT team is always easy to reach: we are
an email or a phone call away and always respond within 24 hours. We provide consulting on the clinical trial strategy and design, regulatory and logistics support, timely updates on clinical trial progress.
Global Standards Compliant Studies
OCT works in full compliance with the international standards (ICH GCP) and FDA/EMA requirements. Since 2005, we
have been guiding our sponsors through
the intricacies of the regulatory system
both when dealing with the Ministry of Health of Russia and FDA or EMA. We are proud of our own set SOPs developed and regularly updated by the Quality Assurance department.
Our goal is to provide sponsors with full transparency from the first inquiry to the final step of the study. Prior to the project start, we conduct thorough analysis and weigh-in of all the potential risks and ambiguities that might arise during the study, and prepare risk-management plan. In case risks occur, all the parties concerned are immediately informed and actions are taken in accordance with the plan.